Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol

Biotechnology Companies

Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCDMO
Avid Bioservices Inc
850.2M
90.6x
---
United States
30.2B
---
-9.28%
United StatesCRL
Charles River Laboratories International Inc
12.4B
29.8x
+18.74%
United StatesEXEL
Exelixis Inc
5.9B
19.9x
---
United StatesGILD
Gilead Sciences Inc
81.3B
18.1x
-13.08%
United StatesHALO
Halozyme Therapeutics Inc
6.7B
16.2x
---
United StatesICLR
ICON PLC
18.5B
91.2x
-13.50%
United StatesIQV
IQVIA Holdings Inc
41.7B
39.8x
+59.92%
United StatesLGND
Ligand Pharmaceuticals Inc
1.5B
67.0x
---
United StatesMRVI
Maravai LifeSciences Holdings Inc
8.7B
18.9x
---
United StatesMRNA
Moderna Inc
58.7B
4.3x
---
United StatesNBIX
Neurocrine Biosciences Inc
8.9B
127.8x
---
United StatesQGEN
Qiagen NV
10.8B
20.4x
+44.61%
United StatesREGN
Regeneron Pharmaceuticals Inc
76.1B
9.8x
+56.36%
United StatesSYNH
Syneos Health Inc
7.7B
32.5x
+1.99%
United StatesVRTX
Vertex Pharmaceuticals Inc
70.0B
28.8x
---
United StatesABCM
Abcam PLC
3.4B
696.7x
---
United StatesABCL
Abcellera Biologics Inc
2.2B
12.1x
---
United StatesRCUS
Arcus Biosciences Inc
1.4B
-1,394.6x
---
United StatesAVIR
Atea Pharmaceuticals Inc
681.0M
16.1x
---
United StatesTECH
Bio-Techne Corp
15.2B
70.5x
+4.37%
United StatesBFAGY
Biofrontera AG
68.4M
4.0x
---
United StatesBMRN
Biomarin Pharmaceutical Inc
15.0B
526.9x
---
United StatesBNTX
BioNTech SE
40.6B
3.0x
---
United StatesCSBR
Champions Oncology Inc
98.3M
241.0x
---
United StatesCLNN
Clene Inc.
144.2M
10.5x
---
United StatesCLGN
Collplant Biotechnologies Ltd
105.4M
36.5x
---
United StatesCMRA
Comera Life Sciences Holdings Inc
47.7M
14.6x
---
United StatesCRSP
CRISPR Therapeutics AG
4.5B
16.2x
---
United StatesDVAX
Dynavax Technologies Corp
1.6B
23.9x
---
United StatesEFTR
eFFECTOR Therapeutics Inc
79.5M
-30.9x
---
United StatesGBLX
GB Sciences Inc
9.0M
2.9x
---
United StatesGNFT
Genfit SA
177.4M
3.2x
---
United StatesGMAB
Genmab A/S
20.0B
58.5x
---
United StatesGRFS
Grifols SA
12.5B
45.6x
---
United StatesHALB
Halberd Corp
8.8M
7.4x
---
United StatesHUMA
Humacyte Inc
566.5M
3.1x
---
United StatesICCC
ImmuCell Corp
64.6M
59.1x
---
United StatesIRWD
Ironwood Pharmaceuticals Inc
1.8B
3.6x
---
United StatesITOS
Iteos Therapeutics Inc
607.4M
2.2x
---
United StatesITRM
Iterum Therapeutics PLC
41.0M
15.0x
---
United StatesLJPC
La Jolla Pharmaceutical Co
96.3M
27.4x
---
United StatesMEDP
Medpace Holdings Inc
4.7B
27.5x
+67.16%
United StatesNBIO
Nascent Biotech Inc
13.7M
41.0x
---
United StatesNWBO
Northwest Biotherapeutics Inc
674.1M
3.7x
---
United StatesNPHC
Nutra Pharma Corp
11.0M
0.7x
---
United StatesOPNT
Opiant Pharmaceuticals Inc
74.6M
32.5x
---
United StatesPRTA
Prothena Corporation PLC
1.3B
23.0x
---
United StatesRGNX
Regenxbio Inc
939.5M
14.3x
---
As of 2022-05-28

Biotechnology

The Biotechnology industry consists of companies engaged in the research and development of new drugs, medical devices and procedures. The industry includes the manufacturing and marketing of drugs as a result of direct research and development. The Biotechnology industry excludes drug manufacturers without research and development operations, and advanced medical equipment wholesalers.

Company Strategies

Companies that have maintained their dividend in the face of falling share price lead to high dividend yields. Attention should be paid to the sustainability of these future payments. Generally companies with high dividend yields are mature, stable companies.

Company Strategies Table
CompanyDividend Yield
United StatesGRFS
Grifols SA - ADR
5.02%
United StatesGILD
Gilead Sciences, Inc.
4.51%
United StatesAZTA
Azenta Inc
0.51%
United StatesTECH
BIO-TECHNE Corp
0.33%
United StatesCDMO
Avid Bioservices Inc
---
At 2022-05-28 04:42 PM ET Data delayed at least 15 minutes.